International Journal of Surgery-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2198723, encodeId=2ece2198e2331, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：外泌体;肿瘤标志物 经验分享：2.29投稿，这杂志双盲审，提交的材料跟其它杂志还不太一样。3.22收到意见，3个reviewer，都比较正向。4.2返修,4.15accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8f8a1685210, createdName=易挥发, createdTime=Tue Apr 16 08:13:50 CST 2024, time=2024-04-16, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2215571, encodeId=0e0a22155e136, content=R3修回之后已经快3个月了，目前是under review状态，日期更换了好多次，基本没10天更换一下，但是状态under review没变，请问这是什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02581648640, createdName=肾内同舟共济, createdTime=Thu Jul 18 13:05:47 CST 2024, time=2024-07-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2204710, encodeId=50562204e1039, content=偏重的研究方向：外科;肿瘤;临床研究 经验分享：2023.11.27投稿，到现在已经快半年了，目前R4，一轮增加一个审稿人，截止目前一共有三个参与审稿，一个没啥意见，两个都是小问题很好回答，但是每次修回就是再under review继续找审稿人，大家有这种情况吗？编辑是什么意思？是不想要吗？是非得找一个负面的审稿人来拒绝吗？真痛苦，太费时间了，哎, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16956388344, createdName=Goldman, createdTime=Tue May 14 19:58:41 CST 2024, time=2024-05-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2211647, encodeId=9305221164e0c, content=这个杂志一审大概多久啊，等的好焦虑。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48716567069, createdName=ms2000000232703096, createdTime=Tue Jun 25 22:18:04 CST 2024, time=2024-06-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2212437, encodeId=e117221243eeb, content=偏重的研究方向：临床手术 经验分享：这个杂志遇到审稿人恶评可以给编辑写信申诉，成功后可能变成accept，第一次拒稿后再次投稿也可以送审，感觉就是十分以上最容易的水刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dca18435542, createdName=新来的小李, createdTime=Sun Jun 30 16:11:03 CST 2024, time=2024-06-30, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2214072, encodeId=b28422140e252, content=可以几个通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=31212443265, createdName=123dca14m69暂无昵称, createdTime=Tue Jul 09 13:57:04 CST 2024, time=2024-07-09, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2215003, encodeId=eff3221500313, content=偏重的研究方向：外科 经验分享：现在这个杂志还接收research letter吗？这种类型算是article还是Letter哦？有人知道吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90876565526, createdName=ms2000000475742884, createdTime=Mon Jul 15 12:02:30 CST 2024, time=2024-07-15, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2213814, encodeId=9fde22138148c, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：外科 经验分享：投了一篇letter，秒拒😂，有谁知道是怎么回事儿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/07/12c20f1926191b0b222fe1cc0b5a7a85.jpg, createdBy=7bf05257864, createdName=147f69e2m39暂无昵称, createdTime=Mon Jul 08 08:02:44 CST 2024, time=2024-07-08, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2211650, encodeId=312322116502e, content=投稿10分钟后变成decision in process, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fad1757723, createdName=ms2129023924590110, createdTime=Tue Jun 25 22:57:25 CST 2024, time=2024-06-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2193356, encodeId=14d02193356f9, content=这个杂志写评论和letter居然都要送审，也是相当奇葩, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dca18435542, createdName=新来的小李, createdTime=Fri Mar 15 11:01:09 CST 2024, time=2024-03-15, status=1, ipAttribution=云南省)]

2024-04-16 易挥发来自广东省

审稿速度:2.0 | 投稿命中率:95.0
偏重的研究方向：外泌体;肿瘤标志物
经验分享：2.29投稿，这杂志双盲审，提交的材料跟其它杂志还不太一样。3.22收到意见，3个reviewer，都比较正向。4.2返修,4.15accept

43 10

展开10条回复

[GetPortalCommentsPageByObjectIdResponse(id=2198723, encodeId=2ece2198e2331, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：外泌体;肿瘤标志物 经验分享：2.29投稿，这杂志双盲审，提交的材料跟其它杂志还不太一样。3.22收到意见，3个reviewer，都比较正向。4.2返修,4.15accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8f8a1685210, createdName=易挥发, createdTime=Tue Apr 16 08:13:50 CST 2024, time=2024-04-16, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2215571, encodeId=0e0a22155e136, content=R3修回之后已经快3个月了，目前是under review状态，日期更换了好多次，基本没10天更换一下，但是状态under review没变，请问这是什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02581648640, createdName=肾内同舟共济, createdTime=Thu Jul 18 13:05:47 CST 2024, time=2024-07-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2204710, encodeId=50562204e1039, content=偏重的研究方向：外科;肿瘤;临床研究 经验分享：2023.11.27投稿，到现在已经快半年了，目前R4，一轮增加一个审稿人，截止目前一共有三个参与审稿，一个没啥意见，两个都是小问题很好回答，但是每次修回就是再under review继续找审稿人，大家有这种情况吗？编辑是什么意思？是不想要吗？是非得找一个负面的审稿人来拒绝吗？真痛苦，太费时间了，哎, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16956388344, createdName=Goldman, createdTime=Tue May 14 19:58:41 CST 2024, time=2024-05-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2211647, encodeId=9305221164e0c, content=这个杂志一审大概多久啊，等的好焦虑。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48716567069, createdName=ms2000000232703096, createdTime=Tue Jun 25 22:18:04 CST 2024, time=2024-06-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2212437, encodeId=e117221243eeb, content=偏重的研究方向：临床手术 经验分享：这个杂志遇到审稿人恶评可以给编辑写信申诉，成功后可能变成accept，第一次拒稿后再次投稿也可以送审，感觉就是十分以上最容易的水刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dca18435542, createdName=新来的小李, createdTime=Sun Jun 30 16:11:03 CST 2024, time=2024-06-30, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2214072, encodeId=b28422140e252, content=可以几个通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=31212443265, createdName=123dca14m69暂无昵称, createdTime=Tue Jul 09 13:57:04 CST 2024, time=2024-07-09, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2215003, encodeId=eff3221500313, content=偏重的研究方向：外科 经验分享：现在这个杂志还接收research letter吗？这种类型算是article还是Letter哦？有人知道吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90876565526, createdName=ms2000000475742884, createdTime=Mon Jul 15 12:02:30 CST 2024, time=2024-07-15, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2213814, encodeId=9fde22138148c, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：外科 经验分享：投了一篇letter，秒拒😂，有谁知道是怎么回事儿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/07/12c20f1926191b0b222fe1cc0b5a7a85.jpg, createdBy=7bf05257864, createdName=147f69e2m39暂无昵称, createdTime=Mon Jul 08 08:02:44 CST 2024, time=2024-07-08, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2211650, encodeId=312322116502e, content=投稿10分钟后变成decision in process, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fad1757723, createdName=ms2129023924590110, createdTime=Tue Jun 25 22:57:25 CST 2024, time=2024-06-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2193356, encodeId=14d02193356f9, content=这个杂志写评论和letter居然都要送审，也是相当奇葩, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dca18435542, createdName=新来的小李, createdTime=Fri Mar 15 11:01:09 CST 2024, time=2024-03-15, status=1, ipAttribution=云南省)]

2024-07-18 肾内同舟共济来自上海

R3修回之后已经快3个月了，目前是under review状态，日期更换了好多次，基本没10天更换一下，但是状态under review没变，请问这是什么情况？

46 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2198723, encodeId=2ece2198e2331, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：外泌体;肿瘤标志物 经验分享：2.29投稿，这杂志双盲审，提交的材料跟其它杂志还不太一样。3.22收到意见，3个reviewer，都比较正向。4.2返修,4.15accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8f8a1685210, createdName=易挥发, createdTime=Tue Apr 16 08:13:50 CST 2024, time=2024-04-16, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2215571, encodeId=0e0a22155e136, content=R3修回之后已经快3个月了，目前是under review状态，日期更换了好多次，基本没10天更换一下，但是状态under review没变，请问这是什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02581648640, createdName=肾内同舟共济, createdTime=Thu Jul 18 13:05:47 CST 2024, time=2024-07-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2204710, encodeId=50562204e1039, content=偏重的研究方向：外科;肿瘤;临床研究 经验分享：2023.11.27投稿，到现在已经快半年了，目前R4，一轮增加一个审稿人，截止目前一共有三个参与审稿，一个没啥意见，两个都是小问题很好回答，但是每次修回就是再under review继续找审稿人，大家有这种情况吗？编辑是什么意思？是不想要吗？是非得找一个负面的审稿人来拒绝吗？真痛苦，太费时间了，哎, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16956388344, createdName=Goldman, createdTime=Tue May 14 19:58:41 CST 2024, time=2024-05-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2211647, encodeId=9305221164e0c, content=这个杂志一审大概多久啊，等的好焦虑。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48716567069, createdName=ms2000000232703096, createdTime=Tue Jun 25 22:18:04 CST 2024, time=2024-06-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2212437, encodeId=e117221243eeb, content=偏重的研究方向：临床手术 经验分享：这个杂志遇到审稿人恶评可以给编辑写信申诉，成功后可能变成accept，第一次拒稿后再次投稿也可以送审，感觉就是十分以上最容易的水刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dca18435542, createdName=新来的小李, createdTime=Sun Jun 30 16:11:03 CST 2024, time=2024-06-30, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2214072, encodeId=b28422140e252, content=可以几个通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=31212443265, createdName=123dca14m69暂无昵称, createdTime=Tue Jul 09 13:57:04 CST 2024, time=2024-07-09, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2215003, encodeId=eff3221500313, content=偏重的研究方向：外科 经验分享：现在这个杂志还接收research letter吗？这种类型算是article还是Letter哦？有人知道吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90876565526, createdName=ms2000000475742884, createdTime=Mon Jul 15 12:02:30 CST 2024, time=2024-07-15, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2213814, encodeId=9fde22138148c, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：外科 经验分享：投了一篇letter，秒拒😂，有谁知道是怎么回事儿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/07/12c20f1926191b0b222fe1cc0b5a7a85.jpg, createdBy=7bf05257864, createdName=147f69e2m39暂无昵称, createdTime=Mon Jul 08 08:02:44 CST 2024, time=2024-07-08, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2211650, encodeId=312322116502e, content=投稿10分钟后变成decision in process, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fad1757723, createdName=ms2129023924590110, createdTime=Tue Jun 25 22:57:25 CST 2024, time=2024-06-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2193356, encodeId=14d02193356f9, content=这个杂志写评论和letter居然都要送审，也是相当奇葩, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dca18435542, createdName=新来的小李, createdTime=Fri Mar 15 11:01:09 CST 2024, time=2024-03-15, status=1, ipAttribution=云南省)]

2024-05-14 Goldman 来自山东省

偏重的研究方向：外科;肿瘤;临床研究
经验分享：2023.11.27投稿，到现在已经快半年了，目前R4，一轮增加一个审稿人，截止目前一共有三个参与审稿，一个没啥意见，两个都是小问题很好回答，但是每次修回就是再under review继续找审稿人，大家有这种情况吗？编辑是什么意思？是不想要吗？是非得找一个负面的审稿人来拒绝吗？真痛苦，太费时间了，哎

30 21

展开21条回复

[GetPortalCommentsPageByObjectIdResponse(id=2198723, encodeId=2ece2198e2331, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：外泌体;肿瘤标志物 经验分享：2.29投稿，这杂志双盲审，提交的材料跟其它杂志还不太一样。3.22收到意见，3个reviewer，都比较正向。4.2返修,4.15accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8f8a1685210, createdName=易挥发, createdTime=Tue Apr 16 08:13:50 CST 2024, time=2024-04-16, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2215571, encodeId=0e0a22155e136, content=R3修回之后已经快3个月了，目前是under review状态，日期更换了好多次，基本没10天更换一下，但是状态under review没变，请问这是什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02581648640, createdName=肾内同舟共济, createdTime=Thu Jul 18 13:05:47 CST 2024, time=2024-07-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2204710, encodeId=50562204e1039, content=偏重的研究方向：外科;肿瘤;临床研究 经验分享：2023.11.27投稿，到现在已经快半年了，目前R4，一轮增加一个审稿人，截止目前一共有三个参与审稿，一个没啥意见，两个都是小问题很好回答，但是每次修回就是再under review继续找审稿人，大家有这种情况吗？编辑是什么意思？是不想要吗？是非得找一个负面的审稿人来拒绝吗？真痛苦，太费时间了，哎, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16956388344, createdName=Goldman, createdTime=Tue May 14 19:58:41 CST 2024, time=2024-05-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2211647, encodeId=9305221164e0c, content=这个杂志一审大概多久啊，等的好焦虑。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48716567069, createdName=ms2000000232703096, createdTime=Tue Jun 25 22:18:04 CST 2024, time=2024-06-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2212437, encodeId=e117221243eeb, content=偏重的研究方向：临床手术 经验分享：这个杂志遇到审稿人恶评可以给编辑写信申诉，成功后可能变成accept，第一次拒稿后再次投稿也可以送审，感觉就是十分以上最容易的水刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dca18435542, createdName=新来的小李, createdTime=Sun Jun 30 16:11:03 CST 2024, time=2024-06-30, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2214072, encodeId=b28422140e252, content=可以几个通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=31212443265, createdName=123dca14m69暂无昵称, createdTime=Tue Jul 09 13:57:04 CST 2024, time=2024-07-09, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2215003, encodeId=eff3221500313, content=偏重的研究方向：外科 经验分享：现在这个杂志还接收research letter吗？这种类型算是article还是Letter哦？有人知道吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90876565526, createdName=ms2000000475742884, createdTime=Mon Jul 15 12:02:30 CST 2024, time=2024-07-15, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2213814, encodeId=9fde22138148c, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：外科 经验分享：投了一篇letter，秒拒😂，有谁知道是怎么回事儿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/07/12c20f1926191b0b222fe1cc0b5a7a85.jpg, createdBy=7bf05257864, createdName=147f69e2m39暂无昵称, createdTime=Mon Jul 08 08:02:44 CST 2024, time=2024-07-08, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2211650, encodeId=312322116502e, content=投稿10分钟后变成decision in process, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fad1757723, createdName=ms2129023924590110, createdTime=Tue Jun 25 22:57:25 CST 2024, time=2024-06-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2193356, encodeId=14d02193356f9, content=这个杂志写评论和letter居然都要送审，也是相当奇葩, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dca18435542, createdName=新来的小李, createdTime=Fri Mar 15 11:01:09 CST 2024, time=2024-03-15, status=1, ipAttribution=云南省)]

2024-06-25 ms2000000232703096 来自四川省

这个杂志一审大概多久啊，等的好焦虑。

32 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2198723, encodeId=2ece2198e2331, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：外泌体;肿瘤标志物 经验分享：2.29投稿，这杂志双盲审，提交的材料跟其它杂志还不太一样。3.22收到意见，3个reviewer，都比较正向。4.2返修,4.15accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8f8a1685210, createdName=易挥发, createdTime=Tue Apr 16 08:13:50 CST 2024, time=2024-04-16, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2215571, encodeId=0e0a22155e136, content=R3修回之后已经快3个月了，目前是under review状态，日期更换了好多次，基本没10天更换一下，但是状态under review没变，请问这是什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02581648640, createdName=肾内同舟共济, createdTime=Thu Jul 18 13:05:47 CST 2024, time=2024-07-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2204710, encodeId=50562204e1039, content=偏重的研究方向：外科;肿瘤;临床研究 经验分享：2023.11.27投稿，到现在已经快半年了，目前R4，一轮增加一个审稿人，截止目前一共有三个参与审稿，一个没啥意见，两个都是小问题很好回答，但是每次修回就是再under review继续找审稿人，大家有这种情况吗？编辑是什么意思？是不想要吗？是非得找一个负面的审稿人来拒绝吗？真痛苦，太费时间了，哎, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16956388344, createdName=Goldman, createdTime=Tue May 14 19:58:41 CST 2024, time=2024-05-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2211647, encodeId=9305221164e0c, content=这个杂志一审大概多久啊，等的好焦虑。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48716567069, createdName=ms2000000232703096, createdTime=Tue Jun 25 22:18:04 CST 2024, time=2024-06-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2212437, encodeId=e117221243eeb, content=偏重的研究方向：临床手术 经验分享：这个杂志遇到审稿人恶评可以给编辑写信申诉，成功后可能变成accept，第一次拒稿后再次投稿也可以送审，感觉就是十分以上最容易的水刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dca18435542, createdName=新来的小李, createdTime=Sun Jun 30 16:11:03 CST 2024, time=2024-06-30, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2214072, encodeId=b28422140e252, content=可以几个通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=31212443265, createdName=123dca14m69暂无昵称, createdTime=Tue Jul 09 13:57:04 CST 2024, time=2024-07-09, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2215003, encodeId=eff3221500313, content=偏重的研究方向：外科 经验分享：现在这个杂志还接收research letter吗？这种类型算是article还是Letter哦？有人知道吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90876565526, createdName=ms2000000475742884, createdTime=Mon Jul 15 12:02:30 CST 2024, time=2024-07-15, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2213814, encodeId=9fde22138148c, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：外科 经验分享：投了一篇letter，秒拒😂，有谁知道是怎么回事儿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/07/12c20f1926191b0b222fe1cc0b5a7a85.jpg, createdBy=7bf05257864, createdName=147f69e2m39暂无昵称, createdTime=Mon Jul 08 08:02:44 CST 2024, time=2024-07-08, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2211650, encodeId=312322116502e, content=投稿10分钟后变成decision in process, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fad1757723, createdName=ms2129023924590110, createdTime=Tue Jun 25 22:57:25 CST 2024, time=2024-06-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2193356, encodeId=14d02193356f9, content=这个杂志写评论和letter居然都要送审，也是相当奇葩, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dca18435542, createdName=新来的小李, createdTime=Fri Mar 15 11:01:09 CST 2024, time=2024-03-15, status=1, ipAttribution=云南省)]

2024-06-30 新来的小李来自云南省

偏重的研究方向：临床手术
经验分享：这个杂志遇到审稿人恶评可以给编辑写信申诉，成功后可能变成accept，第一次拒稿后再次投稿也可以送审，感觉就是十分以上最容易的水刊

111 12

展开12条回复

[GetPortalCommentsPageByObjectIdResponse(id=2198723, encodeId=2ece2198e2331, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：外泌体;肿瘤标志物 经验分享：2.29投稿，这杂志双盲审，提交的材料跟其它杂志还不太一样。3.22收到意见，3个reviewer，都比较正向。4.2返修,4.15accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8f8a1685210, createdName=易挥发, createdTime=Tue Apr 16 08:13:50 CST 2024, time=2024-04-16, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2215571, encodeId=0e0a22155e136, content=R3修回之后已经快3个月了，目前是under review状态，日期更换了好多次，基本没10天更换一下，但是状态under review没变，请问这是什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02581648640, createdName=肾内同舟共济, createdTime=Thu Jul 18 13:05:47 CST 2024, time=2024-07-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2204710, encodeId=50562204e1039, content=偏重的研究方向：外科;肿瘤;临床研究 经验分享：2023.11.27投稿，到现在已经快半年了，目前R4，一轮增加一个审稿人，截止目前一共有三个参与审稿，一个没啥意见，两个都是小问题很好回答，但是每次修回就是再under review继续找审稿人，大家有这种情况吗？编辑是什么意思？是不想要吗？是非得找一个负面的审稿人来拒绝吗？真痛苦，太费时间了，哎, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16956388344, createdName=Goldman, createdTime=Tue May 14 19:58:41 CST 2024, time=2024-05-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2211647, encodeId=9305221164e0c, content=这个杂志一审大概多久啊，等的好焦虑。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48716567069, createdName=ms2000000232703096, createdTime=Tue Jun 25 22:18:04 CST 2024, time=2024-06-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2212437, encodeId=e117221243eeb, content=偏重的研究方向：临床手术 经验分享：这个杂志遇到审稿人恶评可以给编辑写信申诉，成功后可能变成accept，第一次拒稿后再次投稿也可以送审，感觉就是十分以上最容易的水刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dca18435542, createdName=新来的小李, createdTime=Sun Jun 30 16:11:03 CST 2024, time=2024-06-30, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2214072, encodeId=b28422140e252, content=可以几个通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=31212443265, createdName=123dca14m69暂无昵称, createdTime=Tue Jul 09 13:57:04 CST 2024, time=2024-07-09, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2215003, encodeId=eff3221500313, content=偏重的研究方向：外科 经验分享：现在这个杂志还接收research letter吗？这种类型算是article还是Letter哦？有人知道吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90876565526, createdName=ms2000000475742884, createdTime=Mon Jul 15 12:02:30 CST 2024, time=2024-07-15, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2213814, encodeId=9fde22138148c, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：外科 经验分享：投了一篇letter，秒拒😂，有谁知道是怎么回事儿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/07/12c20f1926191b0b222fe1cc0b5a7a85.jpg, createdBy=7bf05257864, createdName=147f69e2m39暂无昵称, createdTime=Mon Jul 08 08:02:44 CST 2024, time=2024-07-08, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2211650, encodeId=312322116502e, content=投稿10分钟后变成decision in process, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fad1757723, createdName=ms2129023924590110, createdTime=Tue Jun 25 22:57:25 CST 2024, time=2024-06-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2193356, encodeId=14d02193356f9, content=这个杂志写评论和letter居然都要送审，也是相当奇葩, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dca18435542, createdName=新来的小李, createdTime=Fri Mar 15 11:01:09 CST 2024, time=2024-03-15, status=1, ipAttribution=云南省)]

2024-07-09 123dca14m69暂无昵称来自福建省

可以几个通讯作者？

24 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2198723, encodeId=2ece2198e2331, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：外泌体;肿瘤标志物 经验分享：2.29投稿，这杂志双盲审，提交的材料跟其它杂志还不太一样。3.22收到意见，3个reviewer，都比较正向。4.2返修,4.15accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8f8a1685210, createdName=易挥发, createdTime=Tue Apr 16 08:13:50 CST 2024, time=2024-04-16, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2215571, encodeId=0e0a22155e136, content=R3修回之后已经快3个月了，目前是under review状态，日期更换了好多次，基本没10天更换一下，但是状态under review没变，请问这是什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02581648640, createdName=肾内同舟共济, createdTime=Thu Jul 18 13:05:47 CST 2024, time=2024-07-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2204710, encodeId=50562204e1039, content=偏重的研究方向：外科;肿瘤;临床研究 经验分享：2023.11.27投稿，到现在已经快半年了，目前R4，一轮增加一个审稿人，截止目前一共有三个参与审稿，一个没啥意见，两个都是小问题很好回答，但是每次修回就是再under review继续找审稿人，大家有这种情况吗？编辑是什么意思？是不想要吗？是非得找一个负面的审稿人来拒绝吗？真痛苦，太费时间了，哎, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16956388344, createdName=Goldman, createdTime=Tue May 14 19:58:41 CST 2024, time=2024-05-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2211647, encodeId=9305221164e0c, content=这个杂志一审大概多久啊，等的好焦虑。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48716567069, createdName=ms2000000232703096, createdTime=Tue Jun 25 22:18:04 CST 2024, time=2024-06-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2212437, encodeId=e117221243eeb, content=偏重的研究方向：临床手术 经验分享：这个杂志遇到审稿人恶评可以给编辑写信申诉，成功后可能变成accept，第一次拒稿后再次投稿也可以送审，感觉就是十分以上最容易的水刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dca18435542, createdName=新来的小李, createdTime=Sun Jun 30 16:11:03 CST 2024, time=2024-06-30, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2214072, encodeId=b28422140e252, content=可以几个通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=31212443265, createdName=123dca14m69暂无昵称, createdTime=Tue Jul 09 13:57:04 CST 2024, time=2024-07-09, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2215003, encodeId=eff3221500313, content=偏重的研究方向：外科 经验分享：现在这个杂志还接收research letter吗？这种类型算是article还是Letter哦？有人知道吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90876565526, createdName=ms2000000475742884, createdTime=Mon Jul 15 12:02:30 CST 2024, time=2024-07-15, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2213814, encodeId=9fde22138148c, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：外科 经验分享：投了一篇letter，秒拒😂，有谁知道是怎么回事儿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/07/12c20f1926191b0b222fe1cc0b5a7a85.jpg, createdBy=7bf05257864, createdName=147f69e2m39暂无昵称, createdTime=Mon Jul 08 08:02:44 CST 2024, time=2024-07-08, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2211650, encodeId=312322116502e, content=投稿10分钟后变成decision in process, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fad1757723, createdName=ms2129023924590110, createdTime=Tue Jun 25 22:57:25 CST 2024, time=2024-06-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2193356, encodeId=14d02193356f9, content=这个杂志写评论和letter居然都要送审，也是相当奇葩, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dca18435542, createdName=新来的小李, createdTime=Fri Mar 15 11:01:09 CST 2024, time=2024-03-15, status=1, ipAttribution=云南省)]

2024-07-15 ms2000000475742884 来自重庆

偏重的研究方向：外科
经验分享：现在这个杂志还接收research letter吗？这种类型算是article还是Letter哦？有人知道吗？

18 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2198723, encodeId=2ece2198e2331, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：外泌体;肿瘤标志物 经验分享：2.29投稿，这杂志双盲审，提交的材料跟其它杂志还不太一样。3.22收到意见，3个reviewer，都比较正向。4.2返修,4.15accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8f8a1685210, createdName=易挥发, createdTime=Tue Apr 16 08:13:50 CST 2024, time=2024-04-16, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2215571, encodeId=0e0a22155e136, content=R3修回之后已经快3个月了，目前是under review状态，日期更换了好多次，基本没10天更换一下，但是状态under review没变，请问这是什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02581648640, createdName=肾内同舟共济, createdTime=Thu Jul 18 13:05:47 CST 2024, time=2024-07-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2204710, encodeId=50562204e1039, content=偏重的研究方向：外科;肿瘤;临床研究 经验分享：2023.11.27投稿，到现在已经快半年了，目前R4，一轮增加一个审稿人，截止目前一共有三个参与审稿，一个没啥意见，两个都是小问题很好回答，但是每次修回就是再under review继续找审稿人，大家有这种情况吗？编辑是什么意思？是不想要吗？是非得找一个负面的审稿人来拒绝吗？真痛苦，太费时间了，哎, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16956388344, createdName=Goldman, createdTime=Tue May 14 19:58:41 CST 2024, time=2024-05-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2211647, encodeId=9305221164e0c, content=这个杂志一审大概多久啊，等的好焦虑。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48716567069, createdName=ms2000000232703096, createdTime=Tue Jun 25 22:18:04 CST 2024, time=2024-06-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2212437, encodeId=e117221243eeb, content=偏重的研究方向：临床手术 经验分享：这个杂志遇到审稿人恶评可以给编辑写信申诉，成功后可能变成accept，第一次拒稿后再次投稿也可以送审，感觉就是十分以上最容易的水刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dca18435542, createdName=新来的小李, createdTime=Sun Jun 30 16:11:03 CST 2024, time=2024-06-30, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2214072, encodeId=b28422140e252, content=可以几个通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=31212443265, createdName=123dca14m69暂无昵称, createdTime=Tue Jul 09 13:57:04 CST 2024, time=2024-07-09, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2215003, encodeId=eff3221500313, content=偏重的研究方向：外科 经验分享：现在这个杂志还接收research letter吗？这种类型算是article还是Letter哦？有人知道吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90876565526, createdName=ms2000000475742884, createdTime=Mon Jul 15 12:02:30 CST 2024, time=2024-07-15, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2213814, encodeId=9fde22138148c, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：外科 经验分享：投了一篇letter，秒拒😂，有谁知道是怎么回事儿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/07/12c20f1926191b0b222fe1cc0b5a7a85.jpg, createdBy=7bf05257864, createdName=147f69e2m39暂无昵称, createdTime=Mon Jul 08 08:02:44 CST 2024, time=2024-07-08, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2211650, encodeId=312322116502e, content=投稿10分钟后变成decision in process, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fad1757723, createdName=ms2129023924590110, createdTime=Tue Jun 25 22:57:25 CST 2024, time=2024-06-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2193356, encodeId=14d02193356f9, content=这个杂志写评论和letter居然都要送审，也是相当奇葩, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dca18435542, createdName=新来的小李, createdTime=Fri Mar 15 11:01:09 CST 2024, time=2024-03-15, status=1, ipAttribution=云南省)]

2024-07-08 147f69e2m39暂无昵称来自吉林省

审稿速度:1.0 | 投稿命中率:5.0
偏重的研究方向：外科
经验分享：投了一篇letter，秒拒😂，有谁知道是怎么回事儿吗

19 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=2198723, encodeId=2ece2198e2331, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：外泌体;肿瘤标志物 经验分享：2.29投稿，这杂志双盲审，提交的材料跟其它杂志还不太一样。3.22收到意见，3个reviewer，都比较正向。4.2返修,4.15accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8f8a1685210, createdName=易挥发, createdTime=Tue Apr 16 08:13:50 CST 2024, time=2024-04-16, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2215571, encodeId=0e0a22155e136, content=R3修回之后已经快3个月了，目前是under review状态，日期更换了好多次，基本没10天更换一下，但是状态under review没变，请问这是什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02581648640, createdName=肾内同舟共济, createdTime=Thu Jul 18 13:05:47 CST 2024, time=2024-07-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2204710, encodeId=50562204e1039, content=偏重的研究方向：外科;肿瘤;临床研究 经验分享：2023.11.27投稿，到现在已经快半年了，目前R4，一轮增加一个审稿人，截止目前一共有三个参与审稿，一个没啥意见，两个都是小问题很好回答，但是每次修回就是再under review继续找审稿人，大家有这种情况吗？编辑是什么意思？是不想要吗？是非得找一个负面的审稿人来拒绝吗？真痛苦，太费时间了，哎, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16956388344, createdName=Goldman, createdTime=Tue May 14 19:58:41 CST 2024, time=2024-05-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2211647, encodeId=9305221164e0c, content=这个杂志一审大概多久啊，等的好焦虑。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48716567069, createdName=ms2000000232703096, createdTime=Tue Jun 25 22:18:04 CST 2024, time=2024-06-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2212437, encodeId=e117221243eeb, content=偏重的研究方向：临床手术 经验分享：这个杂志遇到审稿人恶评可以给编辑写信申诉，成功后可能变成accept，第一次拒稿后再次投稿也可以送审，感觉就是十分以上最容易的水刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dca18435542, createdName=新来的小李, createdTime=Sun Jun 30 16:11:03 CST 2024, time=2024-06-30, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2214072, encodeId=b28422140e252, content=可以几个通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=31212443265, createdName=123dca14m69暂无昵称, createdTime=Tue Jul 09 13:57:04 CST 2024, time=2024-07-09, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2215003, encodeId=eff3221500313, content=偏重的研究方向：外科 经验分享：现在这个杂志还接收research letter吗？这种类型算是article还是Letter哦？有人知道吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90876565526, createdName=ms2000000475742884, createdTime=Mon Jul 15 12:02:30 CST 2024, time=2024-07-15, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2213814, encodeId=9fde22138148c, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：外科 经验分享：投了一篇letter，秒拒😂，有谁知道是怎么回事儿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/07/12c20f1926191b0b222fe1cc0b5a7a85.jpg, createdBy=7bf05257864, createdName=147f69e2m39暂无昵称, createdTime=Mon Jul 08 08:02:44 CST 2024, time=2024-07-08, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2211650, encodeId=312322116502e, content=投稿10分钟后变成decision in process, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fad1757723, createdName=ms2129023924590110, createdTime=Tue Jun 25 22:57:25 CST 2024, time=2024-06-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2193356, encodeId=14d02193356f9, content=这个杂志写评论和letter居然都要送审，也是相当奇葩, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dca18435542, createdName=新来的小李, createdTime=Fri Mar 15 11:01:09 CST 2024, time=2024-03-15, status=1, ipAttribution=云南省)]

2024-06-25 ms2129023924590110 来自北京

投稿10分钟后变成decision in process

30 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2198723, encodeId=2ece2198e2331, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：外泌体;肿瘤标志物 经验分享：2.29投稿，这杂志双盲审，提交的材料跟其它杂志还不太一样。3.22收到意见，3个reviewer，都比较正向。4.2返修,4.15accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8f8a1685210, createdName=易挥发, createdTime=Tue Apr 16 08:13:50 CST 2024, time=2024-04-16, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2215571, encodeId=0e0a22155e136, content=R3修回之后已经快3个月了，目前是under review状态，日期更换了好多次，基本没10天更换一下，但是状态under review没变，请问这是什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02581648640, createdName=肾内同舟共济, createdTime=Thu Jul 18 13:05:47 CST 2024, time=2024-07-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2204710, encodeId=50562204e1039, content=偏重的研究方向：外科;肿瘤;临床研究 经验分享：2023.11.27投稿，到现在已经快半年了，目前R4，一轮增加一个审稿人，截止目前一共有三个参与审稿，一个没啥意见，两个都是小问题很好回答，但是每次修回就是再under review继续找审稿人，大家有这种情况吗？编辑是什么意思？是不想要吗？是非得找一个负面的审稿人来拒绝吗？真痛苦，太费时间了，哎, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16956388344, createdName=Goldman, createdTime=Tue May 14 19:58:41 CST 2024, time=2024-05-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2211647, encodeId=9305221164e0c, content=这个杂志一审大概多久啊，等的好焦虑。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48716567069, createdName=ms2000000232703096, createdTime=Tue Jun 25 22:18:04 CST 2024, time=2024-06-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2212437, encodeId=e117221243eeb, content=偏重的研究方向：临床手术 经验分享：这个杂志遇到审稿人恶评可以给编辑写信申诉，成功后可能变成accept，第一次拒稿后再次投稿也可以送审，感觉就是十分以上最容易的水刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dca18435542, createdName=新来的小李, createdTime=Sun Jun 30 16:11:03 CST 2024, time=2024-06-30, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2214072, encodeId=b28422140e252, content=可以几个通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=31212443265, createdName=123dca14m69暂无昵称, createdTime=Tue Jul 09 13:57:04 CST 2024, time=2024-07-09, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2215003, encodeId=eff3221500313, content=偏重的研究方向：外科 经验分享：现在这个杂志还接收research letter吗？这种类型算是article还是Letter哦？有人知道吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90876565526, createdName=ms2000000475742884, createdTime=Mon Jul 15 12:02:30 CST 2024, time=2024-07-15, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2213814, encodeId=9fde22138148c, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：外科 经验分享：投了一篇letter，秒拒😂，有谁知道是怎么回事儿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/07/12c20f1926191b0b222fe1cc0b5a7a85.jpg, createdBy=7bf05257864, createdName=147f69e2m39暂无昵称, createdTime=Mon Jul 08 08:02:44 CST 2024, time=2024-07-08, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2211650, encodeId=312322116502e, content=投稿10分钟后变成decision in process, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fad1757723, createdName=ms2129023924590110, createdTime=Tue Jun 25 22:57:25 CST 2024, time=2024-06-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2193356, encodeId=14d02193356f9, content=这个杂志写评论和letter居然都要送审，也是相当奇葩, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dca18435542, createdName=新来的小李, createdTime=Fri Mar 15 11:01:09 CST 2024, time=2024-03-15, status=1, ipAttribution=云南省)]

2024-03-15 新来的小李来自云南省

这个杂志写评论和letter居然都要送审，也是相当奇葩

41 8

展开8条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务